This makes them easier to control than other types of
cells used in therapies and makes side effects unlikely.
Not exact matches
Birds, for example, can regenerate hair
cells — and lately researchers have found a few similar effects
in mammals that
used gene and drug
therapy.
Human Longevity has already received $ 70 million
in private backing and aims to
use both genomics and stem
cell therapies to allow us to live longer, healthier lives.
Venter reiterated this sentiment: «
Using the combined power of our core areas of expertise — genomics, informatics, and stem
cell therapies, we are tackling one of the greatest medical / scientific and societal challenges — aging and aging related diseases,» he said
in a statement.
Announced a worldwide collaboration with Sangamo Therapeutics, Inc. (Sangamo)
using Sangamo's zinc finger nuclease technology platform for the development of next - generation ex vivo
cell therapies in oncology.
Using advances
in genomic sequencing, the human microbiome, proteomics, informatics, computing, and
cell therapy technologies, HLI is building the world's most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline.
In the second half of 2017, the United States Food and Drug Administration (FDA) approved two immunotherapies that
use genetically engineered T
cells (CAR - T
cell therapy) to fight cancer.
In a rare appearance Dr. Chandan Sen, Director, OSU Center for Regenerative Medicine & Cell - Based Therapies will explain how this breakthrough came about and how the technology is leading to other medical discoveries and how the principle can be used to generate any tissue out of skin or fat which is abundant in human bod
In a rare appearance Dr. Chandan Sen, Director, OSU Center for Regenerative Medicine &
Cell - Based
Therapies will explain how this breakthrough came about and how the technology is leading to other medical discoveries and how the principle can be
used to generate any tissue out of skin or fat which is abundant
in human bod
in human body.
Cambridge, MA — February 6, 2017 — Aura Biosciences, a biotechnology company developing a new class of
therapies to target and selectively destroy cancer
cells using viral nanoparticle conjugates, announced today that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug application (IND) for the company's lead program, light - activated AU - 011
in ocular melanoma (OM).
Cambridge, MA — March 30, 2017 — Aura Biosciences, a biotechnology company developing a new class of
therapies to target and selectively destroy cancer
cells using viral nanoparticle conjugates, announced today that it has enrolled and dosed the first patient
in its Phase 1b clinical trial of light - activated AU - 011, an investigational, first -
in - class targeted
therapy in development for the treatment of ocular melanoma, a rare and life - threatening disease.
I came across these developing mainstream medical research programs
using adult stem
cell therapy for MS.. It looks interesting and promising, so I wanted to share
in case you haven't seen it: These were the links I found:
First, the interns will gather information about research institutions, academic researchers, and companies conducting work
in adjacent research areas (e.g.
cell therapy company) who are currently
using technologies that are applicable to plant - based and clean meat research or food technology.
Cord blood stem
cells are also often a better option for medical treatments than bone marrow, another option often
used in stem
cell therapies.
«
Used in cancer
therapy, this process could increase the impact of a treatment by heating the cancer
cells while introducing the drug compound into the tumor.»
A type of immune
therapy known as PD - 1 blockade controlled cancer
in 77 percent of patients with defects
in DNA mismatch repair — the system
cells use to spell - check and fix errors
in DNA (SN Online: 10/7/15).
Experts say it could also help to boost supplies of
cells for
use in drug discovery research and could eventually aid production of
cells for
use as
therapies.
A new study has identified a group of molecules
in prostate - cancer
cells that doctors might one day
use to distinguish which patients should be treated with radiation
therapy if rising PSA levels indicate their cancer has recurred after surgical removal of the prostate.
Advanced
Cell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastoc
Cell Technology, based
in Santa Monica California, is developing embryonic stem
cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastoc
cell therapies for macular degeneration and other conditions
using cells obtained non-destructively from an early embryo called a blastocyst.
Even if positive results emerge from these trials, ACT will still face major challenges
in getting an ES -
cell - based
therapy approved for wider
use.
«Cultural revolution
in the study of the gut microbiome: Human gut - on - a-chip technology
used to co-culture gut microbiome, human intestinal
cells could lead to new
therapies for inflammatory bowel diseases.»
A team of researchers at the Stanford University School of Medicine has
used a gene - editing tool known as CRISPR to repair the gene that causes sickle
cell disease
in human stem
cells, which they say is a key step toward developing a gene
therapy for the disorder.
«We concluded that stem
cells used in cardiac
therapy should be drawn from healthy donors or be better genetically engineered for the patient.»
Now a University of Colorado Cancer Center study published online ahead of print
in the journal Oncogene offers compelling evidence explaining this failure and offering a possible strategy for the
use of retinoic acid or other retinoids against some breast cancers: Because early clinical trials are often offered to patients who have already tried other more established
therapies, breast cancer
cells may have been pushed past an important tipping point that offers retinoic acid resistance.
He notes his company had planned this year to apply to the U.S. Food and Drug Administration to
use red blood
cells and platelets derived from iPS
cells in clinical trials, but «at this point,
therapies with these
cells are years off.»
Dr. Zubair, medical and scientific director of the
Cell Therapy Laboratory at Mayo Clinic
in Florida, says the experiment will be the first one Mayo Clinic has conducted
in space and the first to
use these human stem
cells, which are found
in bone marrow.
Restoring normal function to a mutated protein is more difficult than simply blocking a protein, the strategy
used by most medical
therapies, says Klas Wiman, a tumor
cell biologist at the Karolinska Institute
in Stockholm.
«These CAR - T
cells are extremely potent,» Mackall said, noting that a
therapy that
uses CAR - T
cells to treat pediatric leukemia was approved by the Food and Drug Administration
in 2017.
On 13 April, the Texas Medical Board voted to accept rules intended to give doctors «a reasonable and responsible degree of latitude»
in using experimental stem
cell therapies.
When the team
used the retinoid fenretinide along with anti-estrogen
therapy in mouse models of breast cancer, they did not see the expansion of CK5 +
cells previously seen with anti-estrogen
therapy alone.
The act of reprogramming
cells to make them as capable as ones from embryos apparently can result
in aberrant
cells that age and die abnormally, suggesting there is a long way to go to prove such
cells are really like embryonic stem
cells and can find
use in therapies.
And early stage startup Neochromosome, which includes Boeke, intends to raise money to design synthetic chromosomes for medicine that could be
used in an off - the - shelf universal
cell line
in cell therapies and transplants with minimal risk of rejection from the immune system.
«Due to the inhibitory function of Treg
cells, people have been trying to
use these
cells for
therapy in human autoimmune diseases or transplantation,» explains professor Yun Cai Liu, Ph.D., who led the current study.
These include the ability to bring new, innovative products to the market; progress
in oncology, such as the approval of Genentech's drug Avastin for breast cancer and advances
in the
use of gene
therapy, despite some setbacks; continuing progress
in research on stem
cells; the emergence of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.
«This could be useful
in developing new combination
therapies, where multiple drugs are
used simultaneously to treat a cancer by attacking different parts of the cancer
cells at the same time.»
«The discovery of the novel progenitor represents a fundamental advance
in this field and potentially to the liver regeneration field
using cell therapy,» said the study's senior author, Valerie Gouon - Evans, PharmD, PhD, Assistant Professor, in the Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, at the Icahn School of Medicine at Mount Si
cell therapy,» said the study's senior author, Valerie Gouon - Evans, PharmD, PhD, Assistant Professor,
in the Department of Developmental and Regenerative Biology, Black Family Stem
Cell Institute, at the Icahn School of Medicine at Mount Si
Cell Institute, at the Icahn School of Medicine at Mount Sinai.
Nevertheless,» [the] study is very important because it demonstrates for the first time that we can
use gene
therapy to transform
cells in the brain into ones that will secrete GDNF,» says Jeffrey Kordower, a professor of neurological sciences at Rush Presbyterian Medical Center
in Chicago.
«
In order to block tumor recurrence after radiation
therapy, we
used an antibody to target and inhibit these cancer stem
cells,» said Dr. Xu.
Treatment for advanced melanoma has seen success with targeted
therapies — drugs that interfere with division and growth of cancer
cells by targeting key molecules — especially when multiple drugs are
used in combination.
The immediate payoff was a commercialization deal
in age - related macular degeneration
in which Pfizer became the first big pharma company to make a move into the
use of embryonic stem
cells as the basis for a tissue regeneration
therapy.
In a last - ditch effort to save a dying 7 - year - old boy, scientists have
used stem
cells and gene
therapy to replace about 80 percent of his skin.
Early diagnosis could help doctors step
in and
use a new
therapy to preserve brain
cells, he says.
Muscle biologists Qi Long Lu and Terence Partridge at the Medical Research Council Clinical Sciences Centre
in London, U.K., and their colleagues decided to combined the antisense strategy with a chemical often
used in gene
therapy because it is known to improve delivery of DNA into
cells.
«With the rise of new and unproven stem
cell treatments, the NFL faces a daunting task of trying to better understand and regulate the
use of these
therapies in order to protect the health of its players,» said Kirstin Matthews, the Baker Institute fellow
in science and technology policy and an expert on ethical and policy issues related to biomedical research and development.
In addition, the study could improve
therapies using stem
cells.
The researchers were able to reverse these epigenetic changes with the
use of an FDA - approved drug, forcing the cancer
cells out of hiding and potentially making them better targets for the same immune
therapy that
in the past may have failed.
Researchers
used the new
therapy to inhibit a pathway
in the cancer
cells known as mTOR signaling — putting the brakes on this pathway, combined with the current standard
therapy, caused more of the cancer
cells to die.
Meanwhile, Sangamo is testing a
therapy that
uses an older genome editing technique to disrupt CCR5
in patients» CD4 + T -
cells so that HIV is locked out.
By varying the compositions of lipids, cues, and diffusible factors
in the scaffolds, we engineered a very versatile and flexible platform that can be
used to amplify specific T
cell populations from blood samples, and that could be deployed
in existing
therapies such as CAR - T
cell therapies,» said Mooney, Ph.D., a Core Faculty member at the Wyss Institute and leader of its Immunomaterials Platform.
Now, Johns Hopkins researchers report they have
used nanoparticles to successfully deliver a new
therapy to glioma
cells in the brains of rats, prolonging their lives.
We have found that exosomes and the cargo they contain are crucial mediators of stem
cell - based heart regeneration, and we believe this might lead to an even more refined
therapy using the «active ingredient» instead of the entire stem
cell,» said Eduardo Marbán, MD, PhD, director of the Cedars - Sinai Heart Institute and a pioneer
in developing investigational cardiac stem
cell treatments.